Outlook Therapeutics Inc Share Price Today: Live Updates & Key Insights
Outlook Therapeutics Inc share price today is $0.3504, up 4.43%. The stock opened at $0.3429 against the previous close of $0.3362, with an intraday high of $0.37 and low of $0.33505.
Outlook Therapeutics Inc Share Price Chart
Outlook Therapeutics Inc
Outlook Therapeutics Inc Share Price Performance
Outlook Therapeutics Inc Institutional Holdings
Outlook Therapeutics Inc Market Status
Outlook Therapeutics Inc Fundamentals
Market Cap 29.16 M
PB Ratio 10.1912
PE Ratio 0.0
Enterprise Value 56.14 M
Total Assets 18584183.00 M
Volume 1785939
Outlook Therapeutics Inc Company Financials
About Outlook Therapeutics Inc & investment objective
Company Information Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.
Organisation Biotechnology
Employees 17
Industry Biotechnology
CEO Mr. Robert Charles Jahr
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Outlook Therapeutics Inc FAQs
What is the share price of Outlook Therapeutics Inc today?
The current share price of Outlook Therapeutics Inc is $0.3504.
Can I buy Outlook Therapeutics Inc shares in India?
Yes, Indian investors can buy Outlook Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Outlook Therapeutics Inc shares in India?
You can easily invest in Outlook Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Outlook Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Outlook Therapeutics Inc.
Can I buy fractional shares of Outlook Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Outlook Therapeutics Inc?
Outlook Therapeutics Inc has a market cap of $29.16 M.
In which sector does Outlook Therapeutics Inc belong?
Outlook Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Outlook Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Outlook Therapeutics Inc?
The PE ratio of Outlook Therapeutics Inc is N/A and the PB ratio is 10.19.